Here are our top 3 trade ideas today â these setups look primed! Good day, 360 â Here are our top 3 trade ideas today â these setups look primed! And check out our NEWEST addition at the bottom, Market News. Let us know what you think! MDB - MongoDB skyrockets over 27% in after hours on big earnings surprise SMMT - 2nd day play, closed up over 194% yesterday on partnership with Akeso DDOG - Trading in sympathy with MDBâs results [LottoX]( is a fast-paced live training/trading session every Thursday at 12:30pm EST. This is a great opportunity to see some amazing trades at a rock bottom price to test drive it. OVER 63% off for a limited time only! If youâve ever thought of trying Lotto X thereâs never been a better time! >>[Check out this amazing offer for LottoX here](<< MDB - MongoDB skyrockets over 27% in after hours on big earnings surprise MDB reported Q2 EPS of $0.23 vs the -$0.17 estimate. Revenue for the quarter was $333.6 million versus $305.09 consensus. Guidance for the full year 2023 was $0.29-$0.31 vs -$0.31 consensus. MDB reported and guided surprise profitability and this sent the stock over 27% higher in the after-hours. The $186 area was a major prior resistance and is also the pre-market high this morning. That will be an important pivot for today. Above $186 the next target to the upside is $194.5 and then $200. Below $186 there is potential support at $180, then $176 and $170 below that. SMMT - 2nd day play, closed up over 194% yesterday on partnership with Akeso SMMT announced a definitive agreement of partnership with Akeso to license its breakthrough antibody. The deal was worth $5 billion as Akeso is eligible of up to $4.5billion in milestone payments and $500 million up front in exchange for the license. SMMT trended all day on the news and closed near the highs. Yesterdayâs high of $2.34 will be an important pivot for SMMT today. Any short sellers were taken to the woodshed yesterday as the stock closed near the highs. However SMMT is gapping lower this morning so the move could be over. Above $2.31 the next targets to the upside would be $2.80, $3 and $3.44. Below $2.31 there is potential support at $2, then $1.74 then $1.44 below that. DDOG - Trading in sympathy with MDBâs results Datadog (DDOG) is trading 2% higher this morning in sympathy with MDBâs earnings results. Whilst the tech sector and overall market are showing weakness and are in negative territory this morning, DDOG is gapping higher. Being in the same sector as MDB, if MongoDB can hold or even continue higher, traders might look to re-price and scoop up some DDOG shares which may now be relatively cheap given todayâs reaction to MDBâs results. There is after-hours resistance at $70.87. Above it the next targets to the upside would be $72 and then $74 followed by $75 and $75.80. Below $70.87 the next major support level is $68 which would fill the gap. Below that the next stop would be the 52 week lows in DDOG at $66.45 with the next major support level being at $62.50 below that. Todayâs Economic Calendar MBA Mortgage Applications 7:00am ET Productivity and Costs 8:30am ET EIA Petroleum Report 10:30am ET Consumer Credit 3:00pm ET GFX MNG Airlines, a Global Logistics Provider and e-Commerce Enabler, Signs Agreement to Go Public on the New York Stock Exchange Through a Business Combination with Golden Falcon Acquisition Corp. BABA Alibaba's Jack Ma stepped down as the chairman of the General Association of Zhejiang Entrepreneurs, a position that he has held since the establishment of the organization in Oct 2015. Nan Cunhui, the head of the Chint Group, was elected as the new chairman. AAPL Key Apple Supplier Murata Manufacturing Expects iPhone Orders To Drop On Weak Demand AAPL Morgan Stanley cuts Apple's December quarter iPhone shipment estimate by 3 mln to 75.5 mln â Reuters AMZN French watchdog orders Amazon to pay $3.5 mln in penalties â Reuters Top Earning Results After Hours Yesterday: MDB: EPS beat by 43c Rev Beat TOL: EPS beat by $1.65 Rev Beat CPB EPS of $1.02 beats by $0.15, revenue of $2.58B beats by $140M CPB Campbell Soup Q1 22 Earnings: - Net Sales From Cont Ops $2.58B (est $2.45B) - Adj EPS Cont Ops $1.02 (est $0.88) - Raises Year Fiscal 2023 Guidance Beijing City to restore normal production and living order, and resume work and production as soon as possible: municipal govt spokesperson LLY: Phase III trial demonstrated Jardiance® is the first SGLT2 inhibitor to show statistically significant reduction in blood sugar levels in children and adolescents with type 2 diabetes To Your Success! 62 Calef Hwy #233 Lee, New Hampshire 03861 United States Questions or concerns about our products? Email [Support@360wallstreet.](io © Copyright 2022, RagingBull - Refund Policy - Privacy Policy - Terms & Conditions Disclaimers: THIS IS AN ISSUER-PAID ADVERTISEMENT, SEE DISCLOSURE BELOW ISSUER-PAID ADVERTISEMENT: This Issuer has paid RagingBull.com, LLC (âRaging Bullâ) seventeen-thousand five hundred dollars to run advertisements enhancing public awareness of the company. RagingBull is currently invested in this company. DISCLAIMER To more fully understand any Ragingbull.com, LLC ("RagingBull") subscription, website, application or other service ("Services"), please review our full disclaimer located at [( FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Any RagingBull Service offered is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision. RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers' trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment. RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. Employees, owners, and other service providers of []( or RagingBull.com LLC are paid in whole or in part by commission based on their sales of Services to subscribers. [RagingBull.com](, LLC shall be entitled to recover attorneysâ fees, costs and disbursements. In the event that any suit or action is instituted as a result of doing business with [RagingBull.com](, LLC and/or its affiliates or if any suit or action is necessary to enforce or interpret these Terms of Service, [RagingBull.com](, LLC shall be entitled to recover attorneysâ fees, costs and disbursements in addition to any other relief to which it may be entitled. WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services except possibly by advertisers in this email. However, Ragingbull.com, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication. [tw]( Update your email preferences or unsubscribe [here]( © 360wallstreet 62 Calef Hwy. #233
lee, NH 03861, United States [Publish on beehiiv](